Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04904757 · ClinicalTrials.gov registry record · NA
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
A NA study of Mammography and Mammographic Breast Density, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT04904757: Recruiting NA study of Mammography and Mammographic Breast Density, sponsored by University of Virginia.
NCT04904757 is a NA study of Mammography and Mammographic Breast Density that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 210 participants, below the 4,426-participant average among 3 other Mammography trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04904757, a NA study of Mammography and Mammographic Breast Density, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.
Primary Outcome
Plan for primary variable analysis: To evaluate the patient experience during a screening CESM to better understand if women find the experience of contrast injection to be too invasive or unpleasant to repeat or recommend to a friend. Data summarization: Pre and post CESM survey responses that are binary or Likert scaled responses will be summarized by frequencies and percentages. Pre and post CESM survey responses that are continuous scaled responses will be summarized by the mean and standar
Conditions Studied
Interventions
- DEVICE Contrast-enhanced spectral mammography (CESM)
Study Locations (1)
Virginia
- UVA Breast Care Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2023-06 |
| Phase | NA |
What NCT04904757 shows while recruiting
NCT04904757 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 4,426-participant average among 3 other Mammography trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Mammography appearing as the primary indexed condition, and to 1 intervention - of which Contrast-enhanced spectral mammography (CESM) is the first listed.
NCT04904757 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04904757 about?
NCT04904757 is a clinical study titled "Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening". The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.
What is the current status of trial NCT04904757?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2019-09-19. Estimated completion is 2023-06.
What conditions does trial NCT04904757 study?
This clinical trial studies the following conditions: Mammography, Mammographic Breast Density.
What interventions are being tested in trial NCT04904757?
The interventions under investigation include: Contrast-enhanced spectral mammography (CESM) (DEVICE).
Who is sponsoring clinical trial NCT04904757?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04904757 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mammography
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI